11.04.2011
- Swiss drugmaker Novartis will focus on its debts before undertaking any big purchases following its acquisition of eyecare group Alcon, Novartis's chairman was quoted as saying on...
25.01.2011
- Swiss drugmaker Novartis is strengthening its personalized medicine and cancer portfolio with the $470 million buy of U.S. cancer diagnostics company Genoptix. The deal, which...
15.12.2010
- Swiss drugmaker Novartis has finally wrapped up its long-awaited buyout of U.S.-listed Alcon in a $12.9 billion deal after sweetening its original offer with a cash element...
18.11.2010
- Novartis will not go for an all-cash deal to clinch the remaining 23% stake it does not already own in U.S.-listed eyecare group Alcon, Chief Executive Joe Jimenez told Reuters on...
16.11.2010
- Swiss drugmaker Novartis has not ruled out sticking with its 77% stake in U.S.-listed eyecare group Alcon, Novartis Chief Executive Joe Jimenez was quoted as saying on Tuesday....
27.08.2010
- Swiss drugmaker Novartis is pushing ahead with its contentious buyout of Alcon minority shareholders after completing its acquisition of stock from Nestle to get control of the U.S...
23.08.2010
- Swiss drugmaker Novartis is seeking to use Swiss merger law to push through its buy of a minority stake in U.S. Eyecare Group Alcon, which would give it full control of the group...
10.08.2010
- Swiss drugmaker Novartis received approval from EU regulators on Monday to buy a minority stake in Alcon, making it easier for it to take full control of the U.S. eyecare group...
